Products - Diabetes | Topic | NICE

Showing 6 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Type 2 diabetes in adults: management (medicines update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
19 June 2025
Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes [ID6259]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
16 July 2025
Diabetic retinopathy - ruboxistaurin [ID382]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Insulin icodec for treating type 2 diabetes [ID6175]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Cardiometabolic disease prevention and treatment guidelines
Status:
In development
Programme:
NICE Hub
Expected publication date:
TBC